Tatva Chintan Pharma Quarterly Results for Trading Insights
In Mar 2026, Tatva Chintan Pharma (TATVA) reported revenue ₹134 Cr and net profit ₹10 Cr — revenue +22.9% YoY. For annual financials, live price and key ratios, visit TATVA stock price BSE.
TATVA Quarterly Results — Revenue, Profit & EPS Highlights
Tatva Chintan Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Browse TATVA balance sheet details for revenue, profit, balance sheet and cash flow data.
- Revenue of ₹134 Cr in Mar 2026 (-21.2% vs Jun 2026, +22.9% vs Mar 2025)
- Net Profit of ₹10 Cr in Mar 2026 (-37.5% vs Jun 2026, +900.0% vs Mar 2025)
- EBITDA of ₹28 Cr in Mar 2026 (-17.6% vs Jun 2026)
- Operating Margin of 21.0% in Mar 2026 (+2.0pp vs Jun 2026)
- Earnings Per Share of ₹4.41 in Mar 2026 (-35.4% vs Jun 2026)
Tatva Chintan Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS
TATVA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 134 | 170 | 125 | 109 | 118 | -21.2% | 22.9% |
| Net Profit (₹ Cr) | 10 | 16 | 10 | 1 | 7 | - | - |
| EBITDA (₹ Cr) | 28 | 34 | 23 | 10 | 19 | - | - |
| EPS (₹) | 4.41 | 6.83 | 4.24 | 0.44 | 2.84 | - | - |
| Operating Margin (%) | 21.0% | 19.0% | 18.0% | 8.0% | 15.0% | - | - |
TATVA Share Price Trend — 1-Year Movement Across Quarterly Results
Tatva Chintan Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore TATVA price trends to track price trends across different timeframes.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
TATVA vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap
Tatva Chintan Pharma latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Pidilite Industries
Mar 2026 |
₹163,719.34 Cr | 1570.9 | 3,648 | 584 | +1.2% | +13.2% | 16.0% | 276.1 |
|
SRF
Mar 2026 |
₹81,872.54 Cr | 2664.7 | 4,557 | 582 | +28.0% | +7.2% | 12.8% | 135.7 |
|
Coromandel Internat…
Mar 2026 |
₹60,014.83 Cr | 1980.8 | 6,068 | 115 | -37.9% | +11.1% | 1.9% | 417.0 |
|
Linde
Mar 2026 |
₹59,771.45 Cr | 6731.0 | 621 | 77 | -4.5% | +2.6% | 12.4% | 741.3 |
|
Fertilisers & Chemi…
Sept 2025 |
₹52,674.89 Cr | 809.3 | 1,681 | 21 | +48.8% | - | 1.2% | 2529.1 |
All amounts in ₹ Crores